188 related articles for article (PubMed ID: 37428199)
21. [Hodgkin's lymphoma: sensitive and autonomic neuropathy as a paraneoplastic manifestation].
Milanesio M; Vera S; Sturich AG; Guanchiale LA; Figueroa Bonaparte S; Basquiera AL
Medicina (B Aires); 2023; 83(3):484-488. PubMed ID: 37379549
[TBL] [Abstract][Full Text] [Related]
22. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
23. Cerebellar Degeneration as a Rare Paraneoplastic Syndrome in a Child With Hodgkin Lymphoma.
Avramova BE; Hristova T; Yordanova M; Vlahova I; Muchinova A; Bojinova V; Konstantinov D
J Pediatr Hematol Oncol; 2016 Aug; 38(6):470-2. PubMed ID: 26599987
[TBL] [Abstract][Full Text] [Related]
24. [Not Available].
Nilsson AC; Ryding M; Poulsen CA; Blaabjerg M
Ugeskr Laeger; 2023 Mar; 185(11):. PubMed ID: 36999285
[TBL] [Abstract][Full Text] [Related]
25. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
Graus F
Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
[TBL] [Abstract][Full Text] [Related]
26. [Lung cancer and paraneoplastic syndromes].
Jurado Gámez B; García de Lucas MD; Gudín Rodríguez M
An Med Interna; 2001 Aug; 18(8):440-6. PubMed ID: 11589085
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic neurological syndromes associated with ovarian tumors.
Zaborowski MP; Spaczynski M; Nowak-Markwitz E; Michalak S
J Cancer Res Clin Oncol; 2015 Jan; 141(1):99-108. PubMed ID: 24965744
[TBL] [Abstract][Full Text] [Related]
29. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic syndromes: the way to an early diagnosis of lung cancer.
Paraschiv B; Diaconu CC; Toma CL; Bogdan MA
Pneumologia; 2015; 64(2):14-9. PubMed ID: 26506668
[TBL] [Abstract][Full Text] [Related]
32. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.
Graus F; Vogrig A; Muñiz-Castrillo S; Antoine JG; Desestret V; Dubey D; Giometto B; Irani SR; Joubert B; Leypoldt F; McKeon A; Prüss H; Psimaras D; Thomas L; Titulaer MJ; Vedeler CA; Verschuuren JJ; Dalmau J; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34006622
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of paraneoplastic syndrome.
Naschitz JE; Abrahamson J; Yeshurun D
Oncology; 1989; 46(1):40-4. PubMed ID: 2915892
[TBL] [Abstract][Full Text] [Related]
34. Paraneoplastic syndromes in patients with nasopharyngeal cancer.
Toro C; Rinaldo A; Silver CE; Politi M; Ferlito A
Auris Nasus Larynx; 2009 Oct; 36(5):513-20. PubMed ID: 19111998
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic neurological syndromes--diagnosis and management.
Blaes F
Curr Pharm Des; 2012; 18(29):4518-25. PubMed ID: 22612756
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes.
Vatankulu B; Yilmaz Aksoy S; Asa S; Sager S; Sayman HB; Halac M; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):17-21. PubMed ID: 26260889
[TBL] [Abstract][Full Text] [Related]
37. Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.
Manson G; Maria ATJ; Poizeau F; Danlos FX; Kostine M; Brosseau S; Aspeslagh S; Du Rusquec P; Roger M; Pallix-Guyot M; Ruivard M; Dousset L; Grignou L; Psimaras D; Pluvy J; Quéré G; Grados F; Duval F; Bourdain F; Maigne G; Perrin J; Godbert B; Taifas BI; Forestier A; Voisin AL; Martin-Romano P; Baldini C; Marabelle A; Massard C; Honnorat J; Lambotte O; Michot JM
J Immunother Cancer; 2019 Dec; 7(1):337. PubMed ID: 31796119
[TBL] [Abstract][Full Text] [Related]
38. Update on paraneoplastic neurological syndromes.
Didelot A; Honnorat J
Curr Opin Oncol; 2009 Nov; 21(6):566-72. PubMed ID: 19620862
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic syndrome in the course of Hodgkin disease. Case report.
Maggioni F; Zanchin F; Vecchio F; Giordano R; De Zanche L
Ital J Neurol Sci; 1989 Apr; 10(2):207-10. PubMed ID: 2737868
[TBL] [Abstract][Full Text] [Related]
40. Recommended diagnostic criteria for paraneoplastic neurological syndromes.
Graus F; Delattre JY; Antoine JC; Dalmau J; Giometto B; Grisold W; Honnorat J; Smitt PS; Vedeler Ch; Verschuuren JJ; Vincent A; Voltz R
J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1135-40. PubMed ID: 15258215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
